MEDIFAST INC
For the period ended Dec 31, 2023. Filed Feb 20, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 20, 2024
MED$13.03-2.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Net income | $99,415 | $143,568 | $164,031 |
| Other comprehensive income (loss), net of tax: | |||
| Foreign currency translation | (72) | (67) | 112 |
| Unrealized gains (losses) on investment securities | 296 | (20) | (42) |
| Other comprehensive income (loss) | 224 | (87) | 70 |
| Comprehensive income | $99,639 | $143,481 | $164,101 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.